Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 4 studies | 56% ± 23% | |
epithelial cell of proximal tubule | 3 studies | 23% ± 8% |
Insufficient scRNA-seq data for expression of UPB1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 12493.56 | 226 / 226 | 90% | 66.24 | 364 / 406 |
kidney | 100% | 2377.24 | 89 / 89 | 60% | 9.64 | 541 / 901 |
lung | 99% | 164.92 | 573 / 578 | 4% | 0.15 | 51 / 1155 |
uterus | 87% | 63.29 | 148 / 170 | 15% | 0.46 | 68 / 459 |
spleen | 100% | 150.57 | 240 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 362.10 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 206.22 | 849 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 57.67 | 731 / 803 | 0% | 0 | 0 / 0 |
prostate | 89% | 63.34 | 219 / 245 | 0% | 0 | 0 / 502 |
stomach | 79% | 38.42 | 282 / 359 | 5% | 0.17 | 14 / 286 |
brain | 82% | 57.92 | 2163 / 2642 | 1% | 0.01 | 6 / 705 |
thymus | 69% | 35.62 | 450 / 653 | 9% | 0.26 | 55 / 605 |
ovary | 77% | 47.68 | 139 / 180 | 0% | 0 | 0 / 430 |
blood vessel | 76% | 44.02 | 1013 / 1335 | 0% | 0 | 0 / 0 |
intestine | 71% | 39.66 | 687 / 966 | 3% | 0.13 | 14 / 527 |
adipose | 73% | 42.27 | 880 / 1204 | 0% | 0 | 0 / 0 |
breast | 67% | 33.43 | 307 / 459 | 1% | 0.03 | 13 / 1118 |
esophagus | 61% | 37.02 | 888 / 1445 | 3% | 0.08 | 5 / 183 |
tonsil | 0% | 0 | 0 / 0 | 58% | 2.75 | 26 / 45 |
adrenal gland | 51% | 28.60 | 131 / 258 | 6% | 0.21 | 14 / 230 |
bladder | 52% | 24.67 | 11 / 21 | 1% | 0.05 | 7 / 504 |
skin | 40% | 54.79 | 723 / 1809 | 1% | 0.03 | 7 / 472 |
pancreas | 22% | 9.09 | 73 / 328 | 3% | 0.07 | 6 / 178 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.31 | 3 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0046050 | Biological process | UMP catabolic process |
GO_0046079 | Biological process | dUMP catabolic process |
GO_0001889 | Biological process | liver development |
GO_0051289 | Biological process | protein homotetramerization |
GO_0006248 | Biological process | CMP catabolic process |
GO_0001701 | Biological process | in utero embryonic development |
GO_0046135 | Biological process | pyrimidine nucleoside catabolic process |
GO_0006249 | Biological process | dCMP catabolic process |
GO_0033396 | Biological process | beta-alanine biosynthetic process via 3-ureidopropionate |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0003837 | Molecular function | beta-ureidopropionase activity |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | UPB1 |
Protein name | UPB1 protein Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase) Beta-ureidopropionase 1 |
Synonyms | BUP1 DKFZp779O1248 |
Description | FUNCTION: Catalyzes a late step in pyrimidine degradation . Converts N-carbamoyl-beta-alanine (3-ureidopropanoate) into beta-alanine, ammonia and carbon dioxide . Likewise, converts N-carbamoyl-beta-aminoisobutyrate (3-ureidoisobutyrate) into beta-aminoisobutyrate, ammonia and carbon dioxide (Probable). . |
Accessions | A4QPH4 Q6AHZ8 Q9UBR1 ENST00000415388.5 ENST00000382760.2 F8WC94 ENST00000326010.10 |